Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Pancreatic Neoplasms 20Urinary Bladder Neoplasms 8Non-Muscle Invasive Bladder Neoplasms 7Nasopharyngeal Carcinoma 6Biliary Tract Neoplasms 6Nasopharyngeal Neoplasms 5Cholangiocarcinoma 4Ovarian Neoplasms 3Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Breast Neoplasms 3Triple Negative Breast Neoplasms 2Recurrence 2Pancreatic Cancer Resectable 2Neoplasm Metastasis 2Lymphoma, Extranodal NK-T-Cell 2Thyroid Neoplasms 1Rhabdoid Tumor 1Recurrent Platinum-Sensitive Fallopian Tube Endometrioid Adenocarcinoma 1Rare Tumour 1Pancreatic cancer, adult 1Pancreatic Cystic Neoplasm 1Pancreatic Cancer Non-resectable 1PDAC - Pancreatic Ductal Adenocarcinoma 1Mibc 1Melanoma 1Lung Neoplasms 1Lung Diseases, Interstitial 1Locally Advanced Pancreatic Cancer 1Liver Neoplasms 1

Interventions

pembrolizumab 1Vinorelbine 1Pemetrexed 1Paclitaxel 1Nivolumab 1Hypnosis 1Gemcitabine 1Carboplatin 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Lung Diseases, Interstitial × Gemcitabine × Clear all
NCT07420439 2026-04-27

Treatment in Patients With Advanced Non-Small Cell Lung Carcinoma and Interstitial Lung Disease

Intergroupe Francophone de Cancerologie Thoracique

Phase 2 Not yet recruiting
108 enrolled

Lung Diseases, Interstitial

Data powered by HemOnc (CC BY 4.0) Colophon âš¡